Peer Review History

Original SubmissionOctober 22, 2019
Decision Letter - Natalia L. Komarova, Editor

Dear Prof. Michael,

Thank you very much for submitting your manuscript "Predicting lymphatic filariasis elimination in data-limited settings: a reconstructive computational framework for combining data generation and model discovery" for consideration at PLOS Computational Biology.

As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. In light of the reviews (below this email), we would like to invite the resubmission of a significantly-revised version that takes into account the reviewers' comments.

We cannot make any decision about publication until we have seen the revised manuscript and your response to the reviewers' comments. Your revised manuscript is also likely to be sent to reviewers for further evaluation.

When you are ready to resubmit, please upload the following:

[1] A letter containing a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript. Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).

Important additional instructions are given below your reviewer comments.

Please prepare and submit your revised manuscript within 60 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email. Please note that revised manuscripts received after the 60-day due date may require evaluation and peer review similar to newly submitted manuscripts.

Thank you again for your submission. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Natalia L. Komarova

Deputy Editor

PLOS Computational Biology

Natalia Komarova

Deputy Editor

PLOS Computational Biology

***********************

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: The authors have constructed a detailed mathematical analysis of LF transmission in selected sites, engaging in a type of computational exploration which is billed as 'model discovery'. This is a well-established group in the field of LF modeling and have related their work to specific policy questions.

The heart of the presented novelty seems to be Figure 1, where we are told "site specific models" are identified. What does this mean? Does it mean the choice of appropriate parameters based on Table 4? Or does it mean statistical model selection? So little detail is provided that the claims made cannot be evaluated, let alone reproduced.

Selected rather minor comments:

Line 24. "Increasing recognition of the importance of mathematical models" is a dubious claim, as is the remainder of the sentence regarding the plausible-sounding idea that "useful" models "must accurately reflect" processes "pertaining to local infection dynamics". What does _accurately_ really mean in this context? The authors go on to say the models "must be identified", and that is unclear also. Does this refer to statistical identifiability?

Line 39. Claim that the model has provided "critical" information; this is tendentious; recommend omit.

Line 56. "knowledge discovery system'"; recommend omit. What knowledge? Are they talking about baseline values of prevalence?

Reviewer #2: General comments:

The paper presents interesting and useful methods and results that are very relevant to the current landscape of NTD elimination. However, the manuscript is written in a very dense and difficult to digest style. In a number of instances the reader is expected to follow up on multiple references at a time to disentangle single pieces of information vital to the reproducibility of the work. Having followed up on a number of these references it is not always clear what the authors are referring to, making the methods difficult to follow and substantiate. The sentence structure is also often long-winded and over-punctuated, with many sentences stretching over 5 or more lines of text.

The entire manuscript would benefit from rewording to include shorter and more digestible sentences. In addition, the authors should ensure clearer description of the modelling and statistical processes deployed, rather than relying on excessive referencing. Some of these can be including in supplementary but there are a number that would benefit from being included in the main text. This will ensure ease of understanding and reproducibility of the work described.

Specific comments:

Abstract: Excessively long sentences (some up to 5 lines long) make it difficult to read. Consider revising.

49-51 “For many neglected…” Sentence structure is muddled - please revise.

89-92: Consider revising sentence, ideally into two shorter sentences

96-98: Repetition of “data” and general sentence structure/length.

206-208: This doesn’t currently make sense when read through - what does “or any other” refer to here? Please reword.

210: Why are there so many references here? To allow ease of reproducibility you should provide one or two of the most relevant and specific references for the methods being employed. Using a clump of 6 references when describing a single method is inappropriate.

Line 245: How were parameter vectors selected to ensure community mf prevalence distribution was uniform? How did you select/reject samples?

Line 252: Please expand on what this “pre-defined criteria of fit” is

Line 256: Does “single mid-MDA survey” mean a single time point? Why was only a single time point used?

Testing sites (Dokan Tofa, Piapung, Kirare, Giza and Usino Bundi) have no age-stratified mid-MDA data, the age profile has to be derived, so the model is essentially different in these sites than in Seri, Gbuwhen and Maiganga. Make this clearer, how does this impact validation?

273-281: The pruning method described here doesn’t appear to align with any described in the provided reference [47]. I may have missed it (feel free to point it out if so) but if not then please provide a suitable reference to confirm legitimacy of these pruning method.

297-299: How was the reduction in biting rate calculated? What is the functional relationship between ITN and LLIN coverage/efficacy and biting rate? You would expect ITN and LLIN usage to reduce the biting rate, but also reduce the prevalence of infection in the mosquito population, which does not appear to be considered here. The effect is commonly considered to be quadratic (repelling/preventing feeding slows disease acquisition and transmission).

312-313: Waning effect of bednets?

Recrudescence is not a suitable word as used in this manuscript. In a medical sense, recrudescence is the return of detectable symptoms in a patient whose blood stream infection has previously been at such a low level as not to be clinically demonstrable or cause symptoms, it does not refer to the re-establishment of disease at a population level. Resurgence would be a more suitable word.

314-319: How are marginally positive and negative slopes dealt with that could simply represent a maintenance of low-levels of infection rather than a trend towards elimination or resurgence?

323: Reference for Bayesian melding framework should be repeated here.

324-328: Is this supposed to describe the Bayesian melding framework? It sounds like basic approximate bayesian computation. Also the “binary criteria of fit” is not described anywhere in the manuscript. It is mentioned, with reference, in line 252 but not elaborated on what this actually means. This is a vital part of the methodology for reproducibility, please specify explicitly within the manuscript.

332: “fit” should be “fitted”

Figure 1: It’s very hard to see the crosses and circles, with their respective error bars, where they are overlaid. Also the area covered by the model-derived curves is most of the space in a number of plots (e.g. Dokan Tofa CFA). This doesn’t represent an accurate estimate of baseline prevalence, simply that the observed baseline prevalence lies within the very wide range of possibilities predicted by the model. An estimated baseline mf prevalence of between 0 and up to 50% in some age categories (Dokan Tofa, Giza, Piapung) isn’t particularly informative.

Table 3: Is this baseline prevalence? Specify in title.

Table 4: Is ABR here calculated in the complete absence of vector control or is this assuming the low coverage of vector control assumed in the model? Also a number of these (Dolan Tofa, Piapung, Kirare, Usino Bundi, Seri, and Gbuwhen) are within reasonable error of 0.01 mf (1% prevalence), or at least could not be called “markedly lower” as described in line 414. This is reflected by the very low (or zero) resurgence probabilities presented for these settings in Table 5. The highest resurgence probability is seen in Giza, where no bednets are present, which implies to me that the ABR presented in Table 4 may include local bednet usage. This is misleading as it suggests that transmission is naturally higher in Giza, but may mainly be due to a lack of bednet usage.

No rigorous statistical tests of goodness of fit are used in the methods, please justify.

Line 498: This is the range of point estimates with no uncertainty, could be misleading. Including uncertainty these are actually 16-52% mf and 18-91% CFA

**********

Have all data underlying the figures and results presented in the manuscript been provided?

Large-scale datasets should be made available via a public repository as described in the PLOS Computational Biology data availability policy, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer #1: No: I can't tell where the data shown in Supplement Figure 1 are.

Reviewer #2: Yes

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Figure Files:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Data Requirements:

Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example in PLOS Biology see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5.

Reproducibility:

To enhance the reproducibility of your results, PLOS recommends that you deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions, please see http://journals.plos.org/compbiol/s/submission-guidelines#loc-materials-and-methods

Revision 1

Attachments
Attachment
Submitted filename: ReviewerResponseLetter_27 Mar2020.docx
Decision Letter - Natalia L. Komarova, Editor, James Lloyd-Smith, Editor

Dear Prof. Michael,

We are pleased to inform you that your manuscript 'Predicting lymphatic filariasis elimination in data-limited settings: a reconstructive computational framework for combining data generation and model discovery' has been provisionally accepted for publication in PLOS Computational Biology.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Computational Biology. 

Best regards,

James Lloyd-Smith

Associate Editor

PLOS Computational Biology

Natalia Komarova

Deputy Editor

PLOS Computational Biology

***********************************************************

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #2: The manuscript has been much improved.

**********

Have all data underlying the figures and results presented in the manuscript been provided?

Large-scale datasets should be made available via a public repository as described in the PLOS Computational Biology data availability policy, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer #2: Yes

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: No

Formally Accepted
Acceptance Letter - Natalia L. Komarova, Editor, James Lloyd-Smith, Editor

PCOMPBIOL-D-19-01845R1

Predicting lymphatic filariasis elimination in data-limited settings: a reconstructive computational framework for combining data generation and model discovery

Dear Dr Michael,

I am pleased to inform you that your manuscript has been formally accepted for publication in PLOS Computational Biology. Your manuscript is now with our production department and you will be notified of the publication date in due course.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript.

Soon after your final files are uploaded, unless you have opted out, the early version of your manuscript will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting PLOS Computational Biology and open-access publishing. We are looking forward to publishing your work!

With kind regards,

Sarah Hammond

PLOS Computational Biology | Carlyle House, Carlyle Road, Cambridge CB4 3DN | United Kingdom ploscompbiol@plos.org | Phone +44 (0) 1223-442824 | ploscompbiol.org | @PLOSCompBiol

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .